...
首页> 外文期刊>Orbit >Locally advanced sebaceous cell carcinoma (T3) of eyelid: Incidence and pattern of nodal metastases and combined modality management approach
【24h】

Locally advanced sebaceous cell carcinoma (T3) of eyelid: Incidence and pattern of nodal metastases and combined modality management approach

机译:眼睑局部晚期皮脂细胞癌(T3):淋巴结转移的发生率和模式以及联合治疗方法

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Sebaceous carcinoma (SbCC) is a rare malignancy that often mimics benign conditions. Lymphatic involvement, large T3 tumors herald a dismal survival for patients. We present our series of 13 cases of locally advanced SbCC of the eyelid treated at a surgical oncology unit and describe the clinical profile, patterns of nodal spread and recurrence pattern in this subset of SbCC. Methods: A retrospective analysis of case records was carried out for patients presenting with orbital tumors between January 1997 and April 2010 in the department of Surgical Oncology, AIIMS, New Delhi, India. All patients underwent orbital exenteration and superficial parotidectomy with neck dissection was added to patients with clinically significant lymphadenopathy. All patients who underwent OE after 2002 were advised radiotherapy as adjuvant therapy. The end point was development of recurrence or end of two year follow up period which ever occurred earlier. Results: Thirteen patients underwent orbital exenteration. Eleven patients had clinically palpable lymphadenopathy. Ten patients (76.9%) had pathologically confirmed metastatic nodes. Parotid lymph node involvement was present in all patients (100%); two of these ten patients also had level II b cervical lymph node involvement. Recurrence was observed in seven patients (53.8%). All recurrences were loco-regional only and no systemic metastases was seen. There were only two recurrences in the group that received PORT. Conclusions: Eyelid SbCC is a loco-regionally aggressive malignancy and adequate disease control can be achieved with combined modality approach of radical surgery followed by post operative radiotherapy.
机译:背景:皮脂腺癌(SbCC)是一种罕见的恶性肿瘤,通常模仿良性疾病。淋巴管受累,大的T3肿瘤预示着患者生存惨淡。我们介绍了在外科肿瘤科治疗的13例眼睑局部进展的SbCC系列病例,并描述了该SbCC子集中的临床概况,淋巴结扩散模式和复发模式。方法:回顾性分析1997年1月至2010年4月在印度新德里AIIMS外科肿瘤科进行的眼眶肿瘤患者的病例记录。所有患者均经过眼眶摘除术,并进行了具有颈淋巴清扫术的浅表腮腺切除术,并被纳入具有临床意义的淋巴结病患者。建议所有在2002年之后接受OE治疗的患者接受放射治疗作为辅助治疗。终点是复​​发的发展或两年随访期的结束,这是较早发生的。结果:13例患者接受了眼眶摘除术。 11例患者有临床上可触及的淋巴结肿大。 10名患者(占76.9%)具有经病理证实的转移性淋巴结。所有患者均出现腮腺淋巴结受累(100%);这十名患者中有两名也患有IIb级颈淋巴结受累。 7例患者(53.8%)观察到复发。所有的复发仅在局部发生,未见全身性转移。接受PORT的组中只有两次复发。结论:眼睑SbCC是局部局部侵袭性恶性肿瘤,根治性手术联合术后放射疗法可实现适当的疾病控制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号